Takeda and Dr. Reddy's Partner to Distribute Dengue Vaccine QDENGA in India
Takeda Pharmaceutical and Dr. Reddy's Laboratories have entered an exclusive agreement to promote and distribute Takeda's dengue vaccine, QDENGA, in India's private market for individuals aged 4 to 60. Following approval by India's Central Drugs Standard Control Organization in July 2026, the vaccine is expected to be available in the first half of 2027. This collaboration aims to enhance dengue prevention efforts, with long-term goals of broader access and potential inclusion in public immunization programs.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (75/100). Lens Score 51/100.
Outlets measured: thehindu, thetribune. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (75–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thetribune broke this story on 21 Sept, 12:15 pm. Other outlets followed.